Reuters logo
BRIEF-INSYS THERAPEUTICS EXTENDS ‘COMPASSIONATE USE’ STUDIES OF CANNABIDIOL FOR REFRACTORY PEDIATRIC EPILEPSY
October 9, 2017 / 1:08 PM / 14 days ago

BRIEF-INSYS THERAPEUTICS EXTENDS ‘COMPASSIONATE USE’ STUDIES OF CANNABIDIOL FOR REFRACTORY PEDIATRIC EPILEPSY

Oct 9 (Reuters) - INSYS Therapeutics Inc:

* INSYS THERAPEUTICS - EXTENDED COMPASSIONATE USE STUDIES OF ITS PROPRIETARY ORAL FORMULATION OF CANNABIDIOL FOR TREATMENT OF REFRACTORY PEDIATRIC EPILEPSY​

* INSYS THERAPEUTICS - ‍DECIDED TO EXTEND EXPANDED ACCESS PROGRAM DUE TO PATIENTS’ CONTINUED RESPONSE TO TREATMENT WITH CO‘S FORMULATION OF CBD ORAL SOLUTION​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below